23.5 C
New York
Thursday, July 3, 2025

Tag: impression

《The 36th Golden Melody Awards》

Trout Fresh Crowned Best Male Singer(Mandarin), Waa Wei Named Best Female Singer(Mandarin) International Superstar MISIA Delivers a Stunning Performance TAIPEI, July 3, 2025 /PRNewswire/ -- The 36th...

《The 36th Golden Melody Awards》

Trout Fresh Crowned Best Male Singer(Mandarin), Waa Wei Named Best Female Singer(Mandarin) International Superstar MISIA Delivers a Stunning Performance TAIPEI, July 3, 2025 /PRNewswire/ -- The 36th...

APPLOVIN ALERT: Bragar Eagel & Squire, P.C. is Investigating AppLovin Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against AppLovin Corporation (NASDAQ:APP) on behalf of long-term stockholders following a class action complaint that was filed against AppLovin on March 5, 2025 with a Class Period from May 10, 2023 to March 26, 2025.. Our investigation concerns whether the board of directors of AppLovin have breached their fiduciary duties to the company.

KidVestors and GiveAshare Partner to Turn Financial Literacy into Real Stock Ownership for Kids and Teens

LOUISVILLE, Ky. and GILBERT, Ariz., July 1, 2025 /PRNewswire/ -- In a groundbreaking partnership aimed at transforming the way kids and teens learn about...

New Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Outcomes in SMA

CAMBRIDGE, Mass., June 27, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced new data that reinforce the clinical impact of nusinersen across a broad spectrum of individuals affected by spinal muscular atrophy (SMA). These latest findings from Part C of the DEVOTE trial evaluating a higher dose regimen of nusinersen and the NURTURE trial which evaluated the approved 12 mg regimen (SPINRAZA®) in clinically presymptomatic SMA were presented at the SMA Research & Clinical Care Meeting hosted by Cure SMA in Anaheim, Calif. Biogen’s applications for the higher dose regimen of nusinersen are currently under review in the U.S., Europe, Japan and other global markets. The higher dose regimen of nusinersen comprises a more rapid loading regimen – two 50 mg doses 14 days apart – and a higher maintenance regimen – 28 mg every four months.

INVESTMENT OUTLOOK EYES DISCIPLINE AMID VOLATILITY

American Century's chief investment officers' insights on patience amid off-the-charts uncertainty KANSAS CITY, Mo., June 26, 2025 /PRNewswire/ -- Amid a year marked by economic...

1-800-STRIPER® Set To Paint The Town: Budget-Friendly Paved Lot Maintenance Comes To Maple Grove

Established pavement striping company launches fresh franchise location in Maple Grove, offering property owners affordable striping options for worn out parking lots, sport courts,...

Volta Finance Limited – Net Asset Value(s) as at 31 May 2025


Volta Finance Limited (VTA / VTAS)
May 2025 monthly report


NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES

TC Transcontinental acquiert Middleton Group afin de poursuivre la croissance de ses activités de marketing sur le lieu de vente

MONTRÉAL, 23 juin 2025 (GLOBE NEWSWIRE) -- TC Transcontinental (TSX : TCL.A TCL.B) annonce aujourd'hui l'acquisition de Middleton Group, un fournisseur de services au commerce de détail et de solutions d'affichage au point de vente pour les principaux détaillants et marques nord-américains. Cette acquisition stratégique vient appuyer la croissance des activités de marketing sur le lieu de vente (MLV) de TC Transcontinental dans un marché au potentiel de croissance prometteur où l'entreprise occupe déjà une position de chef de file au Canada.

NSSC DEADLINE TUESDAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NAPCO Security Technologies, Inc. Investors to Secure Counsel Before Important June 24 Deadline in Securities Class...

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NAPCO Security Technologies, Inc. (NASDAQ: NSSC) between February 5, 2024 and February 3, 2025, both dates inclusive (the “Class Period”), of the important June 24, 2025 lead plaintiff deadline.

Moehl Millwork Showcases Glenview Doors in 8,000 sq ft Showroom

ANKENY, Iowa, June 20, 2025 /PRNewswire/ -- Moehl Millwork introduces Glenview entry doors designed to enhance the curb appeal and energy efficiency of homes...

Global Times hosts China-Russia Literature Salon in Beijing

BEIJING, June 19, 2025 /PRNewswire/ -- To thoroughly study, promote, and implement Xi Jinping Thought on Culture and to advance mutual learning between Chinese and...

A Date with Light and Shadow Across Thousands of Miles: Beijing International Film Festival Shines in Sydney

BEIJING, CHINA, June 19, 2025 (GLOBE NEWSWIRE) -- This year, the Beijing International Film Festival made its Australian debut, hosting a special promotional event on June 13 during the 72nd Sydney International Film Festival, marking a fresh encounter between Chinese cinematic culture and audiences in the Southern Hemisphere. Australia is a land that has not only nurtured a rich and unique geographical landscape but has also produced diverse masterpieces that have made their mark on the international film scene, such as "Memoir of a Snail," "Hacksaw Ridge," "Mad Max: Fury Road," and "Moulin Rouge." As the country's most representative film event, the Sydney International Film Festival brings together outstanding films and creators from around the world, allowing this harbor city to showcase its unique cultural charm through the interplay of light and shadow.

ANAVEX SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Long-Term Investors to Contact the Firm

PHILADELPHIA, June 16, 2025 (GLOBE NEWSWIRE) -- The law firm of Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Anavex Life Sciences Corp. (NASDAQ: AVXL) (“Anavex”) on behalf of the company’s long-term shareholders. 

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsImpression